Reviewable Unit (RPS)

Main Page | Regulated Clinical Research Information Management | Regulated Product Submissions | RPS Glossary

This page provides a list of Definitions for the RPS project. RPS Definitions are suffixed with "(RPS)" to avoid confusion with other projects' definitions on this Wiki.

This article is under construction

RPS Submission

This is a Glossary page

R1 Working Definition

Collection of one or more submission units that collectively become part of a submission. [not fully discussed]

ICH Equivalent

none

BRIDG Term

Reviewable Unit (???) A discrete portion of a submission which is used to receive agreement. Once agreement is reached on all units within the submission the submission can then be approved.

For example, in a Modular pre-marketing application (PMA) several modules will be sent to the Food & Drug Administration (FDA). Each module will be agreed upon independently of other modules. The FDA then approves the submission based on compilation of all of the modules. These modules are reviewable units.

For example, a veterinary medicine New Animal Drug Application (NADA) (marketing application) is constructed from the Investigational New Animal Drug Application (INADA). In the INADA process the sponsor creates reviewable units. These reviewable units are then compiled to be used as documentation for the marketing application.